151 related articles for article (PubMed ID: 24422475)
1. Applying the Fe(III) binding property of a chemical transferrin mimetic to Ti(IV) anticancer drug design.
Parks TB; Cruz YM; Tinoco AD
Inorg Chem; 2014 Feb; 53(3):1743-9. PubMed ID: 24422475
[TBL] [Abstract][Full Text] [Related]
2. Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.
Loza-Rosas SA; Vázquez-Salgado AM; Rivero KI; Negrón LJ; Delgado Y; Benjamín-Rivera JA; Vázquez-Maldonado AL; Parks TB; Munet-Colón C; Tinoco AD
Inorg Chem; 2017 Jul; 56(14):7788-7802. PubMed ID: 28644630
[TBL] [Abstract][Full Text] [Related]
3. Calorimetric, spectroscopic, and model studies provide insight into the transport of Ti(IV) by human serum transferrin.
Tinoco AD; Incarvito CD; Valentine AM
J Am Chem Soc; 2007 Mar; 129(11):3444-54. PubMed ID: 17315875
[TBL] [Abstract][Full Text] [Related]
4. Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride.
Guo M; Sun H; McArdle HJ; Gambling L; Sadler PJ
Biochemistry; 2000 Aug; 39(33):10023-33. PubMed ID: 10955990
[TBL] [Abstract][Full Text] [Related]
5. Ti(IV) binds to human serum transferrin more tightly than does Fe(III).
Tinoco AD; Valentine AM
J Am Chem Soc; 2005 Aug; 127(32):11218-9. PubMed ID: 16089431
[TBL] [Abstract][Full Text] [Related]
6. Redox potentials of Ti(IV) and Fe(III) complexes provide insights into titanium biodistribution mechanisms.
Parker Siburt CJ; Lin EM; Brandt SJ; Tinoco AD; Valentine AM; Crumbliss AL
J Inorg Biochem; 2010 Sep; 104(9):1006-9. PubMed ID: 20569990
[TBL] [Abstract][Full Text] [Related]
7. Titanium preferential binding sites in human serum transferrin at physiological concentrations.
Nuevo-Ordoñez Y; Montes-Bayón M; Blanco González E; Sanz-Medel A
Metallomics; 2011 Dec; 3(12):1297-303. PubMed ID: 22041858
[TBL] [Abstract][Full Text] [Related]
8. Unusual Synergism of Transferrin and Citrate in the Regulation of Ti(IV) Speciation, Transport, and Toxicity.
Tinoco AD; Saxena M; Sharma S; Noinaj N; Delgado Y; Quiñones González EP; Conklin SE; Zambrana N; Loza-Rosas SA; Parks TB
J Am Chem Soc; 2016 May; 138(17):5659-65. PubMed ID: 27070073
[TBL] [Abstract][Full Text] [Related]
9. Vanadium(V/IV)-Transferrin Binding Disrupts the Transferrin Cycle and Reduces Vanadium Uptake and Antiproliferative Activity in Human Lung Cancer Cells.
Levina A; Lay PA
Inorg Chem; 2020 Nov; 59(22):16143-16153. PubMed ID: 32578416
[TBL] [Abstract][Full Text] [Related]
10. Superstoichiometric Binding of the Anticancer Agent Titanocene Dichloride by Human Serum Transferrin and the Accompanying Lobe Closure.
Profitt LA; Baxter RHG; Valentine AM
Biochemistry; 2022 May; 61(9):795-803. PubMed ID: 35373558
[TBL] [Abstract][Full Text] [Related]
11. Electronic structure and spectro-structural correlations of Fe(III)Zn(II) biomimetics for purple acid phosphatases: relevance to DNA cleavage and cytotoxic activity.
Peralta RA; Bortoluzzi AJ; de Souza B; Jovito R; Xavier FR; Couto RA; Casellato A; Nome F; Dick A; Gahan LR; Schenk G; Hanson GR; de Paula FC; Pereira-Maia EC; de P Machado S; Severino PC; Pich C; Bortolotto T; Terenzi H; Castellano EE; Neves A; Riley MJ
Inorg Chem; 2010 Dec; 49(24):11421-38. PubMed ID: 21080710
[TBL] [Abstract][Full Text] [Related]
12. Hydrolytic metal with a hydrophobic periphery: titanium(IV) complexes of naphthalene-2,3-diolate and interactions with serum albumin.
Tinoco AD; Eames EV; Incarvito CD; Valentine AM
Inorg Chem; 2008 Sep; 47(18):8380-90. PubMed ID: 18710217
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of a Ti(IV) compound is independent of serum proteins.
Tinoco AD; Thomas HR; Incarvito CD; Saghatelian A; Valentine AM
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5016-21. PubMed ID: 22411801
[TBL] [Abstract][Full Text] [Related]
14. Unusual features for zirconium(IV) binding to human serum transferrin.
Zhong W; Parkinson JA; Guo M; Sadler PJ
J Biol Inorg Chem; 2002 Jun; 7(6):589-99. PubMed ID: 12072964
[TBL] [Abstract][Full Text] [Related]
15. Chemical evaluation of HBED/Fe(3+) and the novel HJB/Fe(3+) chelates as fertilizers to alleviate iron chlorosis.
López-Rayo S; Hernández D; Lucena JJ
J Agric Food Chem; 2009 Sep; 57(18):8504-13. PubMed ID: 19689133
[TBL] [Abstract][Full Text] [Related]
16. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.
Peri D; Meker S; Manna CM; Tshuva EY
Inorg Chem; 2011 Feb; 50(3):1030-8. PubMed ID: 21214265
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure, spectra and reactivity of iron(III) complexes of facially coordinating and sterically hindering 3N ligands as models for catechol dioxygenases.
Sundaravel K; Dhanalakshmi T; Suresh E; Palaniandavar M
Dalton Trans; 2008 Dec; (48):7012-25. PubMed ID: 19050788
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
19. Reconsideration of serum Ti(IV) transport: albumin and transferrin trafficking of Ti(IV) and its complexes.
Tinoco AD; Eames EV; Valentine AM
J Am Chem Soc; 2008 Feb; 130(7):2262-70. PubMed ID: 18225897
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional consequences of binding site mutations in transferrin: crystal structures of the Asp63Glu and Arg124Ala mutants of the N-lobe of human transferrin.
Baker HM; He QY; Briggs SK; Mason AB; Baker EN
Biochemistry; 2003 Jun; 42(23):7084-9. PubMed ID: 12795604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
